With its proton beam fully optimized from the proton source to final shaping, the MEVION S250 creates the high-conformance treatment geometries required for the most demanding cancer cases. And with a modern three-tiered control architecture including complete information system integration, clinicians can maximize target dose, minimize healthy-tissue dose, and achieve higher treatment accuracy – safely and effectively.

Mevion’s dedicated TriNiobium Core proton source, in each treatment room, eliminates downtime while waiting for beam access. The MEVION S250 also streamlines treatment delivery with state-of-the-art image guidance, a simple-to-use operator’s environment, and connectivity to existing oncology information and treatment planning systems. Analogous to a linac in terms of footprint, workflow, and throughput, the MEVION S250 provides a remarkably ‘conventional’ means of delivering cutting-edge cancer care.

The MEVION S250 Proton Therapy System is USFDA 510(k) cleared and complies with MDD/CE requirements